Sameer Kalghatgi, Ph.D., a former postdoctoral fellow in Collins laboratory who is now Senior Plasma Scientist at EP Technologies in Akron, Ohio, and Catherine S
Health-conscious individuals concerned about metabolic health, those with family histories of diabetes or cardiovascular disease, and patients experiencing unexplained fatigue, weight changes, or vision problems should consider this screening (Epicentre 2025)
At a high level, the two medications have remarkably similar goals
GlucagonLike Peptide1 Receptor Agonists and Cardiovascular Events in Adults With Obesity and Autoimmune Disease: A Target Trial Emulation
Journal of Clinical Medicine
The choice ultimately depends on your lifestyle, your comfort level with needles, and your specific metabolic needs